RxDoctor Payments DataLook up a doctor →

James Wheeler, MD

General Practice · Atlanta, GANPI 1619922960

Payments from drug & device makers

$12,542in general payments, 2019–2025

Across 766 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Amgen$766
  • AstraZeneca$707
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$572
  • Pfizer$547
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$12,523100%
  • Education$60%
  • Entertainment$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)150$1,926
Novo Nordisk115$1,543
Amgen47$766
AstraZeneca(2 entities)40$707
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC31$572
Pfizer33$547
Lilly USA, LLC29$449
Supernus Pharmaceuticals, Inc.14$435
Neos Therapeutics, LP17$398
Takeda Pharmaceuticals U.S.A., Inc.27$385
Sanofi-aventis U.S. LLC22$371
Amarin Pharma, Inc.15$303
Astellas Pharma US Inc14$248
Abbott12$246
Biohaven Pharmaceuticals, Inc.6$226
GSK14$219
Kowa Pharmaceuticals America, Inc.18$214
Biohaven Pharmaceutical Holding Company Ltd.9$182
Madrigal Pharmaceuticals6$173
Boehringer Ingelheim10$170
Corium, LLC7$136
Eisai Inc.8$133
Tris Pharma Inc7$132
Jazz Pharmaceuticals Inc.6$128
Dexcom, Inc.7$127
Merck10$124
Exact Sciences8$122
Bayer5$117
Arbor Pharmaceuticals, Inc.5$95
Teva Pharmaceuticals USA, Inc.6$95
Esperion Therapeutics, Inc.5$87
Axsome Therapeutics, Inc.4$84
Ironshore Pharmaceuticals Inc.4$82
Shire North American Group Inc5$80
Gilead5$74
Topcon Healthcare Solutions, Inc.2$65
Portola Pharmaceuticals, LLC1$57
Idorsia Pharmaceuticals US Inc3$55
Vivus LLC4$53
Upsher-smith Laboratories LLC3$53
Noven Therapeutics, LLC2$44
Daiichi Sankyo Inc.2$41
Ironwood Pharmaceuticals, Inc3$39
Currax Pharmaceuticals LLC2$29
Bausch Health US, LLC2$29
Amneal Pharmaceuticals LLC2$28
Vanda Pharmaceuticals Inc.1$28
Collegium Pharmaceutical, Inc.1$24
Saluda Medical Americas, Inc.1$24
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$22
Impel Pharmaceuticals Inc.1$22
Biotronik NRO, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$20
Medtronic1$19
Sanofi Pasteur Inc.1$19
Phathom Pharmaceuticals, Inc.1$18
Sumitomo Pharma America, Inc.1$18
Aytu Biopharma, Inc.1$17
Philips North America LLC1$16
Avanir Pharmaceuticals, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,542 in reported general payments places this provider in the 95th percentile of 2,542 general practice providers in Georgia.

See all general practice providers in Georgia

Medicare billing

Part B allowed, 2024
$250,566
Medicare patients
491
Services billed
3,652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide58$63,931
JardianceEmpagliflozin18$20,144
EliquisApixaban22$18,598
XareltoRivaroxaban13$16,977
VyvanseLisdexamfetamine Dimesylate16$8,216
Lisdexamfetamine Dimesylate25$8,031
BelsomraSuvorexant15$6,709
LivaloPitavastatin Calcium11$6,644
ArexvyRsvpref3 Antigen/As01e/Pf17$5,124
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,583
Boostrix TdapDiphth,pertuss(Acell),tet Vac39$2,691
Bupropion XlBupropion Hcl25$2,197
Testosterone11$1,621
Celecoxib44$1,469
Ezetimibe21$1,332

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$449$63,93158 claims
Boehringer IngelheimJardiance$170$20,14418 claims
PfizerEliquis$547$18,59822 claims
GSKArexvy, Shingrix$219$9,70738 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$385$8,21616 claims
MerckBelsomra$124$6,70915 claims
Kowa Pharmaceuticals America, Inc.Livalo$214$6,64411 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$28$50854 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,542 general practice providers in Georgia.

Other general practice in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →